About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

High Dosage Radiotherapy Does Not Improve Prostate Cancer Survival Rates

by Anjali Aryamvally on April 1, 2018 at 1:07 PM
Font : A-A+

High Dosage Radiotherapy Does Not Improve Prostate Cancer Survival Rates

High-dose radiotherapy did not improve survival for men with intermediate-risk prostate cancer but did improve biochemical control and rates of distant metastases, when compared to standard radiotherapy, shows results of a recent NRG Oncology study.

Prostate cancer patients who received higher-dose radiotherapy underwent fewer salvage therapies to control tumors that had grown larger or had spread to another body site; however, they also experienced more side effects than did men on the standard radiotherapy treatment arm.

Advertisement


This information will be invaluable for doctors and patients when deciding the best treatment course. Research efforts on this study were led by the Study Chair, Jeff M. Michalski, MD, of the Siteman Cancer Center at the Washington University School of Medicine in St. Louis. This analysis was published in JAMA Oncology and Dr. Michalski was recently interviewed by JAMA Oncology in a podcast regarding the publication.

NRG Oncology/RTOG 0126 is the first study of its kind large enough to examine whether improvement in cancer control from escalating radiotherapy dose could convert into longer overall survival rates for such patients. The trial analyzed 1,499 participants: 748 men were randomly assigned to the experimental radiotherapy arm to receive the higher dose of 79.2Gy in 44 fractions, and 751 men were randomly assigned to the standard radiotherapy arm to receive 70.2Gy in 39 fractions. At the median follow-up time of 8.4 years, there was no difference in overall survival. The 8-year overall survival for patients who received the escalated dose of radiotherapy was 76% and the 8-year overall survival for the standard radiotherapy dose was 75%. There were more late grade 2 or greater gastrointestinal and genitourinary toxicities reported (occurring more than 90 days from start of treatment) for patients on the higher-dose radiotherapy arm (5-year cumulative incidence [GI/GU]: 21%/12% with 79.2Gy versus 15%/7% with 70.2Gy). However, the experimental arm had a lower rate of salvage therapies.
Advertisement

"If we can safely deliver the higher dose of radiotherapy, my opinion is to do that," Michalski advised. "It does show lower risk of recurrence, which results in better quality of life. But if we can't achieve those 'safe' radiotherapy dose goals, we shouldn't put the patient at risk of serious side effects down the line by giving the higher dose. If we can't spare the rectum or the bladder well enough, for example, we should probably back off the radiotherapy dose. It's important to develop treatment plans for each patient on a case-by-case basis."



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
International Day of Persons with Disabilities 2021 - Fighting for Rights in the Post-COVID Era
Effect of Blood Group Type on COVID-19 Risk and Severity
Woman with Rare Spinal Cord Defect from Birth Sues Doctor
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Radiotherapy Prostate Cancer Cancer and Homeopathy Trans-Urethral Resection of the Prostate Hodgkins Lymphoma Non-Hodgkins Lymphoma Prostate Cancer Facts Cancer Facts Cancer Tattoos A Body Art 

Recommended Reading
MicroRNAs Promote Tumor Growth in Metastatic Prostate Cancers
Study finds a secreted microRNA molecule that alters bone structure in late-stage prostate cancer....
Prostate Cancer Drug Most Effective When Paired With Good Food
Taking abiraterone acetate, marketed as Zytiga, a standard prostate cancer drug with food boosts ......
Impact of Prostate Cancer on Wives – The Other Side of Prostate Cancer
Wives of advanced prostate cancer sufferers feel that their lives are being undermined by their ......
Artificial Intelligence can Diagnose Prostate Cancer Accurately
Artificial intelligence learning system has been developed that aids in diagnosing and identifying ....
Hodgkins Lymphoma
Hodgkins lymphoma or Hodgkins disease has the distinction of being the first cancer to be cured by c...
Non-Hodgkins Lymphoma
Non Hodgkins Lymphoma is a cancer that affects the lymph tissues. It is made up of a wide array of ....
Prostate Cancer
This cancer affects men over the age of 50 years and screening with rectal examination and PSA can h...
Radiotherapy
A detailed account of radiation, its mode of action, side effects and dosage in the treatment of ......
Tattoos A Body Art
Tattoos are a rage among college students who sport it for the ‘cool dude’ or ‘cool babe’ look...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use